# A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

> **NCT01511003** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 128 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT01511003
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-05
- **Primary completion:** 2015-05-11
- **Final completion:** 2015-05-11
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2018-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511003, "A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01511003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*